Multitude AG (MULT)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 5.560 |
|---|---|
| 52-week range | 4.870 – 7.160 |
| Return, 1 month / 3 months | −4.1% / +3.7% |
| Return, 1 year / 3 years | −11.3% / +123.6% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 42.7% |
| Worst drawdown (1 year) | -21.2% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 10.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Multitude is a financial technology company based in Finland that provides consumer lending and business financing to customers across Europe and other markets. Through its lending brands it offers small personal loans and credit lines to individuals, while its business arm supplies working capital and financing to small and medium-sized enterprises. It also operates a mobile banking service aimed at business customers, combining deposit accounts with lending products.
Multitude AG trades under the code MULT on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Multitude AG (MULT) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 5.560 on 23 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 392 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.3% and over the last three months it rose 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.0% | ||
| From 52-week high | -20.3% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.7% | ||
| 6-month return | -7.7% | ||
| 12-month return, skipping the last month | -7.5% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.2% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 10.7% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | −4.1% |
| 3 months | +3.7% |
| 6 months | −7.7% |
| 1 year | −11.3% |
| 3 years | +123.6% |
| 5 years | +38.8% |
Signals
| 50-day / 200-day average | 5.801 / 5.674 |
|---|---|
| Golden / death cross (60 days) | Golden, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.172 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | CHF 0.5500 |
| 15 May 2025 | CHF 0.4400 |
| 26 Apr 2024 | CHF 0.1900 |
| 18 Apr 2019 | CHF 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.